Insulet (Nasdaq:PODD) shares ticked up today on third-quarter results that came in well ahead of the consensus forecast.

Tandem Diabetes Care shares ticked up after hours today on third-quarter results that topped the consensus forecast.

Insulet's wearable pump, called a Pod, eliminates the need for multiple daily insulin injections for diabetics. Follow Kimberley Koenig for more stock market news on X/Twitter @IBD_KKoenig.

Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...

The stocks for both Swiss and Israeli biotechs were up over 20% after the companies signed a merger agreement.

The stock's valuation is attractive ... with sales rising 18% to nearly $880 million. Even Lilly's insulin product Humalog, ...

At about $69 per share, DexCom's stock isn't that far off its 52-week low of $62.34 ... for diabetics who aren't using ...

Insulin prices have skyrocketed in recent years, working a hardship on the growing number of diabetics in the US. Progressive ...

Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) were down 9.6% on Friday after Canaccord Genuity Group lowered their price target on the stock from $57.00 to $56.00. Canaccord ...

The stock has more than doubled in 2024 but is still trading under $5. Investors are growing increasingly optimistic that imetelstat could gain additional approvals. Geron is in phase 3 clinical ...

Crypto stocks and small-caps have gained in the lead up to the election ... She has pledged to cut healthcare costs by ...

Insulin is a hormone that regulates your blood sugar levels ... Berries, bananas and apples are simple and delicious ...